证券代码：688628 证券简称：优利德 公告编号：2025-033 优利德科技（中国）股份有限公司 关于首次公开发行股票募投项目结项 并拟注销募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 优利德科技（中国）股份有限公司（以下简称"公司"）首次公开发行股票 募集资金投资项目 "高端测量仪器与热成像研发中心项目"（以下简称"募投 项目"）已完成募集资金承诺投资，该项目的募集资金已基本使用完毕，公司决 定将上述募投项目结项，将节余募集资金 87.41 万元永久补充流动资金，并注销 上述募投项目募集资金专用账户，后续公司计划以自有资金继续投入项目建设。 根据《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相 关规定，该事项可以免于履行董事会审议程序，无需监事会、保荐机构或者独立 财务顾问发表明确同意意见。现将相关情况公告如下： 一、募集资金基本情况 | | | | 预计投资总 | | | | --- | --- | --- | --- | --- | --- | | 序号 | 项目名称 | ...

北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 法律意见 东莞市南城总部基地蜂汇广场 1 栋 31 楼、35 楼 电话:0769-23229888 传真:0769-23226999 邮编:523000 北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 德恒 29F20220004-0008 号 致：优利德科技（中国）股份有限公司 北京德恒（东莞）律师事务所（以下简称"本所"）接受优利德科技（中国） 股份有限公司（以下简称"优利德"或"公司"）委托，担任公司专项法律顾问。 本所根据《中华人民共和国公司法》 （以下简称《公司法》）、 《中华人民共和国证 券法》（以下简称《证券法》）、《上市公司股权激励管理办法》（以下简称《股权 激励管理办法》）、 《上海证券交易所科创板股票上市规则》 （以下简称《上市规则》）、 《科创板上市公司自律监管指南第 4 号——股权激励信息披露》等相关法律、法 规、规范性文件、 《优利德科技（中国）股份有限公司章程》 （以下简称《公司章 程》）以及《优利德科技（中国）股份有限公司 2022 年限 ...

证券代码：688628 证券简称：优利德 公告编号：2025-032 回购股份数量（股） 注销股份数量（股） 注销日期 一、本次限制性股票回购注销决策与信息披露 （一）公司于 2025 年 4 月 11 日召开第三届董事会第八次会议、第三届监事 会第八次会议，审议通过了《关于调整 2022 年限制性股票激励计划回购价格及 回购注销部分第一类限制性股票的议案》，同意将公司本次激励计划第一类限制 性股票回购价格由 15.39 元/股调整为 14.09 元/股，并同意回购注销因公司层面业 绩考核及个人绩效考核原因而不得解除限售的第一类限制性股票合计 3.816 万 股。具体内容详见公司于 2025 年 4 月 12 日在上海证券交易所网站及指定媒体 披露的《关于调整 2022 年限制性股票激励计划回购价格及回购注销部分第一类 限制性股票的公告》（公告编号：2025-014）。 优利德科技（中国）股份有限公司 关于2022年限制性股票激励计划部分第一类限制性 股票回购注销实施公告 （二）公司已根据法律规定就本次第一类限制性股票回购注销事项履行通知 债权人程序，详见公司于 2025 年 4 月 12 日在上海证券交易所 ...

（一）公司于 2025 年 4 月 11 日召开第三届董事会第八次会议、第三届监事 会第八次会议，审议通过了《关于调整 2022 年限制性股票激励计划回购价格及 回购注销部分第一类限制性股票的议案》，同意将公司本次激励计划第一类限制 性股票回购价格由 15.39 元/股调整为 14.09 元/股，并同意回购注销因公司层面业 绩考核及个人绩效考核原因而不得解除限售的第一类限制性股票合计 3.816 万 股。具体内容详见公司于 2025 年 4 月 12 日在上海证券交易所网站及指定媒体 披露的《关于调整 2022 年限制性股票激励计划回购价格及回购注销部分第一类 限制性股票的公告》（公告编号：2025-014）。 证券代码：688628 证券简称：优利德 公告编号：2025-032 优利德科技（中国）股份有限公司 关于2022年限制性股票激励计划部分第一类限制性 股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 回购注销原因：根据优利德科技（中国）股份有限公司（以下简称"公 司"）2022 ...

北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 2022 年限制性股票激励计划相关事项的 法律意见 东莞市南城总部基地蜂汇广场 1 栋 31 楼、35 楼 电话:0769-23229888 传真:0769-23226999 邮编:523000 北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 2022 年限制性股票激励计划相关事项的法律意见 北京德恒（东莞）律师事务所 关于优利德科技（中国）股份有限公司 对本法律意见，本所律师作出如下声明： 1. 本所律师依据《证券法》《律师事务所从事证券法律业务管理办法》和《律 师事务所证券法律业务执业规则（试行）》等规定及本法律意见出具之日以前已 1 2022 年限制性股票激励计划相关事项的法律意见 德恒 29F20220004-0008 号 致：优利德科技（中国）股份有限公司 北京德恒（东莞）律师事务所（以下简称"本所"）接受优利德科技（中国） 股份有限公司（以下简称"优利德"或"公司"）委托，担任公司专项法律顾问。 本所根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、《上市公司股权激励 ...

证券代码：688628 证券简称：优利德 公告编号：2025-033 优利德科技（中国）股份有限公司 关于首次公开发行股票募投项目结项 并拟注销募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 优利德科技（中国）股份有限公司（以下简称"公司"）首次公开发行股票 募集资金投资项目 "高端测量仪器与热成像研发中心项目"（以下简称"募投 项目"）已完成募集资金承诺投资，该项目的募集资金已基本使用完毕，公司决 定将上述募投项目结项，将节余募集资金 87.41 万元永久补充流动资金，并注销 上述募投项目募集资金专用账户，后续公司计划以自有资金继续投入项目建设。 根据《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相 关规定，该事项可以免于履行董事会审议程序，无需监事会、保荐机构或者独立 财务顾问发表明确同意意见。现将相关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意优利德科技（中国）股份有限公司首 次公开发行股票注册的批复》（证监许可[2020]3663 号文）文件核准， ...

Industry Rating - The report maintains an "Outperform" rating for the scientific instruments industry, consistent with the previous rating [1]. Core Insights - The scientific instruments market in China surpassed 220 billion yuan in 2023, with a growth rate exceeding 12%. The market is dominated by high-end foreign brands, and there is a significant push for domestic alternatives driven by government policies [2][12]. - The domestic market for mass spectrometers reached 16.712 billion yuan in 2023, with foreign companies holding over 90% of the global market share. The import rate for mass spectrometers has decreased from 89% in 2018 to 81% in 2023, indicating a gradual shift towards domestic production [3][41]. - The electronic measurement instruments market is projected to exceed 40 billion yuan in 2024, with a notable focus on mid-to-high-end products. The market for oscilloscopes is expected to reach 650 million USD by 2025 [4]. Summary by Sections 1. Scientific Instruments Industry - The scientific instruments industry is characterized by high-end foreign brands dominating the market, while domestic brands struggle to gain market share. The government has introduced various policies to promote domestic innovation and application of scientific instruments [2][24]. 2. Scientific Analysis Instruments - The market for scientific analysis instruments is vast, with mass spectrometers and chromatographs showing low domestic production rates. The mass spectrometer market is expected to grow significantly, with a focus on high-resolution and triple quadrupole models as key areas for domestic manufacturers to target [25][50]. 3. Electronic Measurement Instruments - The electronic measurement instruments market is rapidly expanding, with a projected market size of 16.307 billion USD globally by 2024. The domestic market is expected to exceed 40 billion yuan, with a significant portion of high-end products still being imported [4][6]. 4. Policy Guidance - Recent government policies have aimed to support the development of domestic scientific instruments, including tax exemptions for imported instruments used in research and education, which will lower costs for research institutions [21][24].

Industry Overview - The level gauge market in China is well-developed, reflecting strong domestic demand for high-end products, particularly in precision manufacturing and semiconductor testing [1][10] - In the first five months of 2025, China imported 20,000 level gauges, a year-on-year increase of 47.25%, with an import value of 27.72 million yuan, up 33.50% [1][10] - Exports reached 9.57 million units, growing 18.38%, with an export value of 834 million yuan, a modest increase of 1.33% [1][10] Industry Development History - The industry has evolved through four main stages: state-led development (1949-1978), market transformation (1979-2000), globalization (2001-2014), and intelligent transformation (2015-present) [4][5][6] - The introduction of electronic technology has shifted the market towards electronic level gauges, enhancing precision and efficiency [5] - The current phase emphasizes smart manufacturing and the integration of IoT and AI technologies into level gauge production [6] Industry Supply Chain - The upstream supply chain includes raw materials like metals and optical materials, while the midstream focuses on manufacturing [8] - Downstream applications span construction, mechanical processing, industrial installation, and aerospace [8] Current Industry Status - The import of high-end level gauges is driven by the urgent need for precision measurement in advanced manufacturing sectors [10] - The export market is characterized by a "volume compensates for price" strategy, with increasing competition leading to a "revenue without profit" scenario [10] Key Enterprises - Leading companies like Laisai Laser and Suzhou Fudian dominate the high-end market, leveraging technology and patents to maintain competitive advantages [16][19] - Laisai Laser's products are widely used in major national projects, while Suzhou Fudian has developed innovative products with high precision [16][19] Industry Development Trends - The industry is experiencing a surge in technological innovation and smart development, with smart level gauges becoming a new growth engine [21] - The demand for high-precision level gauges is increasing, particularly in the automotive and semiconductor sectors, driving product upgrades [22] - Government policies are fostering innovation and sustainability in the industry, with a focus on green technologies and compliance with safety standards [23]

Group 1 - The stock of Youlide (688628) has a comprehensive score of 53.64, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 33.50 CNY, 5-day main cost at 33.41 CNY, 20-day main cost at 33.02 CNY, and 60-day main cost at 33.58 CNY [1] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - The short-term resistance level is at 33.72 CNY, while the short-term support level is at 33.01 CNY [2] - The market trend is currently unclear, with a wait-and-see approach regarding the direction of main funds [2] - The K-line pattern indicates a potential upward movement, with a "bullish cannon" formation suggesting possible price increases [2] Group 3 - On July 3, 2025, the net inflow of main funds was 368.21 million CNY, accounting for 12% of the total transaction volume [2] - Large orders contributed a net inflow of 260.08 million CNY, while retail investors experienced a net outflow of 29.10 million CNY [2] - Related industry sectors include Instrumentation (0.75%), IoT (0.77%), Medical Devices (0.76%), and Nuclear Pollution Prevention (-0.80%) [2]

Group 1 - The core business of the company is the research, production, and sales of testing and measuring instruments, with major products including testing instruments, general instruments, temperature and environmental testing instruments, and specialized instruments [2] - The company achieved a revenue of 311 million yuan in Q1 2025, representing a year-on-year increase of 9.58%, and a net profit of 55.11 million yuan, with a year-on-year increase of 0.91%, and a gross profit margin of 42.96% [2] - The company has received several awards for its technological advancements, including a first prize for the "Research and Industrialization of New Portable Vibration Measurement and Analysis Instrument" project and a second prize for the "Key Technology Research and Large-scale Application of Power System Physical and Chemical Testing Robot" project [2] Group 2 - The company's current price-to-earnings (PE) ratio is 20.61, with a total market capitalization of 3.79 billion yuan [1][3] - The average PE ratio in the instrument and meter industry is 77.61, with a median of 54.13, placing the company at the 22nd position in the industry ranking [1][3] - As of Q1 2025, there are 20 institutions holding shares in the company, including 13 funds, 5 others, and 2 brokerages, with a total holding of 73.05 million shares valued at 2.80 billion yuan [1]